MedTrace Logo

Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer

NCT01683864 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2018-01-30

Study results available
· View outcomes & findings →

Summary

Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer

Conditions

Interventions

DRUG

positive cytology with HIPEC

HIPEC with mytomycin and cisplatin

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Alfred Königsrainer, MD · University Hospital Tuebingen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01683864 on ClinicalTrials.gov